Consort Medical plc (LON:CSRT)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $864.34 and traded as high as $768.02. Consort Medical shares last traded at $755.00, with a volume of 8,047 shares traded.
A number of brokerages have commented on CSRT. Numis Securities cut Consort Medical to a “hold” rating in a research note on Thursday, June 6th. Shore Capital reaffirmed a “buy” rating on shares of Consort Medical in a research note on Monday, July 15th. Finally, Royal Bank of Canada decreased their price target on Consort Medical from GBX 1,320 ($17.25) to GBX 1,130 ($14.77) and set an “outperform” rating on the stock in a research note on Thursday, June 13th.
The stock has a market capitalization of $372.70 million and a P/E ratio of 35.85. The stock has a 50-day moving average price of GBX 764.22 and a two-hundred day moving average price of GBX 863.39. The company has a debt-to-equity ratio of 46.56, a quick ratio of 1.04 and a current ratio of 1.63.
In related news, insider Chris Brinsmead bought 1,000 shares of the company’s stock in a transaction on Friday, August 2nd. The shares were acquired at an average cost of GBX 732 ($9.56) per share, with a total value of £7,320 ($9,564.88). Also, insider Jonathan Glenn sold 14,908 shares of the business’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of GBX 726 ($9.49), for a total value of £108,232.08 ($141,424.38).
About Consort Medical (LON:CSRT)
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Featured Story: S&P 500 Index
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.